Received Sep 11, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| VARZOS | ZOSTER (SHINGRIX) | GLAXOSMITHKLINE BIOLOGICALS | 3 | — | IM |
PATIENT RECEIVED THIRD DOSE OF ZOSTER (SHINGRIX). HE COMPLETED DOSES 1 AND 2 ON 11/13/2019 AND 3/18/2020, RESPECTIVELY.
PATIENT HAD RECEIVED RECOMINANT ZOSTER ON 11/13/2019 & 03/18/2020. DOSE HE RECEIVED LAST WEEK FROM PHARMACY WAS THIRD DOSE WHICH IS OUTSIDE OF NECESSARY DOSES.
OBSTRUCTIVE SLEEP APNEA, LOW BACK PAIN, PERIPHERAL ARTERIAL OCCLUSIVE DISEASE, T2DM, COPD, HTN, HYPERLIPIDEMIA, GERD, CORONARY ARTERY DISEASE, INSOMNIA, AFTRICAL FIBRILLATION, HEART FAILURE